FindTrial
Sign In

New Biomarker Identification and Quantification for Parkinsons and Diabetes

LC-HRMS based exploration for the Biomarker of Parkinson disease and its correlation with Diabetes - NIL

Status
Unknown
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085916
Enrollment
150
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G319- Degenerative disease of nervous system, unspecified Health Condition 2: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Nil: Nil

Sponsors

Ravi P Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic, Non-diabetic

Exclusion criteria

Exclusion criteria: People with neurological disorders other than PD, severe Anemic patients

Design outcomes

Primary

MeasureTime frame
To identify and quantify biomarker and understand their correlationTimepoint: NA—

Secondary

MeasureTime frame
Generate normal level of modification of Aplha Syn or other modification due to oxidative stressTimepoint: NA—

Countries

India

Contacts

Public ContactRavi P Shah

National Institute of Pharmaceutical Education and Research (NIPER)-Ahmedabad

ravi.shah@niperahm.res.in7966745555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026